Newbanks Mike
Known title: VP Finance & CAOCIK: 0001727810
Associated companies
Transaction History
| CSPI | ▲ Buy | Grant | 8,500 | $0 | 1/5/2024 | View on chart |
| CSPI | ▲ Buy | Grant | 8,500 | $0 | 1/6/2023 | View on chart |
| CSPI | ▲ Buy | Grant | 7,000 | $0 | 1/6/2022 | View on chart |
| CSPI | ▲ Buy | Grant | 8,500 | $0 | 1/5/2024 | View on chart |
| CSPI | ▲ Buy | Grant | 8,500 | $0 | 1/6/2023 | View on chart |
| CSPI | ▲ Buy | Grant | 7,000 | $0 | 1/6/2022 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
CSPI Expands Pharma Cybersecurity with AZT PROTECT Deployment
CSPI announced it is expanding its cybersecurity services into the pharmaceutical sector by deploying the AZT PROTECT solution. The move was highlighted by both CSPI and ARIA Cybersecurity, showing a new partnership with a leading pharma manufacturer. This development signals growth in CSPI’s pharma cybersecurity offering and may strengthen its position in that market.
CSPI Expands Pharma Cybersecurity with AZT PROTECT Deployment. CSPI announced it is expanding its cybersecurity services into the pharmaceutical sector by deploying the AZT PROTECT solution. The move was highlighted by both CSPI and ARIA Cybersecurity, showing a new partnership with a leading pharma manufacturer. This development signals growth in CSPI’s pharma cybersecurity offering and may strengthen its position in that market.